MGNet Webinar: Investigating Immune Mechanisms Underlying Checkpoint Inhibitor Myasthenia Gravis

Описание к видео MGNet Webinar: Investigating Immune Mechanisms Underlying Checkpoint Inhibitor Myasthenia Gravis

The Myasthenia Gravis Rare Disease Network (MGNet) team initiated a new series of video interviews with MGNet investigators. The purpose of this project is to bring a researcher’s work to the MG patient community. This is the fourth episode of the series featuring Dr. Gianvito Masi, 2022 MGNet Scholar.

Комментарии

Информация по комментариям в разработке